141 related articles for article (PubMed ID: 22022327)
1. Changes of pulmonary pathology and gene expressions after simvastatin treatment in the monocrotaline-induced pulmonary hypertension rat model.
Lee YH; Kim KC; Cho MS; Hong YM
Korean Circ J; 2011 Sep; 41(9):518-27. PubMed ID: 22022327
[TBL] [Abstract][Full Text] [Related]
2. Changes of gene expression after bone marrow cell transfusion in rats with monocrotaline-induced pulmonary hypertension.
Kim KC; Lee HR; Kim SJ; Cho MS; Hong YM
J Korean Med Sci; 2012 Jun; 27(6):605-13. PubMed ID: 22690090
[TBL] [Abstract][Full Text] [Related]
3. An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model.
Kwon JH; Kim KC; Cho MS; Kim HS; Sohn S; Hong YM
Korean J Pediatr; 2013 Mar; 56(3):116-24. PubMed ID: 23559973
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
[TBL] [Abstract][Full Text] [Related]
5. Gene expressions of nitric oxide synthase and matrix metalloproteinase-2 in monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.
Koo HS; Kim KC; Hong YM
Korean Circ J; 2011 Feb; 41(2):83-90. PubMed ID: 21430993
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment.
Lim KA; Kim KC; Cho MS; Lee BE; Kim HS; Hong YM
Korean Circ J; 2010 Sep; 40(9):459-64. PubMed ID: 20967148
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.
Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN
Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854
[TBL] [Abstract][Full Text] [Related]
9. Effect of Ambrisentan Therapy on the Expression of Endothelin Receptor, Endothelial Nitric Oxide Synthase and NADPH Oxidase 4 in Monocrotaline-induced Pulmonary Arterial Hypertension Rat Model.
Lee H; Yeom A; Kim KC; Hong YM
Korean Circ J; 2019 Sep; 49(9):866-876. PubMed ID: 31165592
[TBL] [Abstract][Full Text] [Related]
10. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.
Yen CH; Leu S; Lin YC; Kao YH; Chang LT; Chua S; Fu M; Wu CJ; Sun CK; Yip HK
J Cardiovasc Pharmacol; 2010 Jun; 55(6):574-84. PubMed ID: 20224427
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
Jiang L; Zhou T; Liu H
Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats.
Yao J; Xiong M; Tang B; Chen G; Liang M; Ma X; Wang Z; Wu Z
Eur J Cardiothorac Surg; 2012 Nov; 42(5):e121-7. PubMed ID: 23087098
[TBL] [Abstract][Full Text] [Related]
15. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin, sildenafil and their combination in monocrotaline induced pulmonary arterial hypertension.
Lee DS; Kim YK; Jung YW
Korean Circ J; 2010 Dec; 40(12):659-64. PubMed ID: 21267389
[TBL] [Abstract][Full Text] [Related]
17. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
Zhao L; Zhou TF; Liu HM; Li M; Dou H; Tang ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
[TBL] [Abstract][Full Text] [Related]
18. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
Li XL; Guan RJ; Xu QH; Wu ZY
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):247-53. PubMed ID: 21609531
[TBL] [Abstract][Full Text] [Related]
19. Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension.
Takahashi T; Kanda T; Inoue M; Sumino H; Kobayashi I; Iwamoto A; Nagai R
Life Sci; 1998; 63(10):PL137-43. PubMed ID: 9734710
[TBL] [Abstract][Full Text] [Related]
20. [Protective effects of beraprost plus simvastatin on monocrotaline-induced pulmonary arterial hypertension in rats].
Wang SH; Liu S; Yang JH; Wang ZZ; Li J; Hou WW
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1691-5. PubMed ID: 24124673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
